Seraseq 20 Variant Tumor DNA Mix

Tumor DNA analysis has been a key driver to enable personalized medicine. Laboratories are routinely evaluating the mutations present in tumor biopsies to help match patients with the most efficacious medicines.

In response to requests from labs running these tests, we created Seraseq 20 Variant Tumor DNA Mix with a larger fill volume, smaller number of targets and more attractive price point for routine use. This carefully designed product still has the uncompromising commitment to quality present in all of our products but we worked closely with academic medical labs to find the right balance to better support the post-validation reference material needs of smaller labs.